Specifications
Species Reactivity
Mouse; Rat; Human
Immunogen
Recombinant human alpha synuclein, produced in E.coli.
Applications
Application Notes
IHC-FoFr: 1/300; Flow Cyt: 1μg/106 cells; WB: 1/100 - 1/10000; IHC-P: 1/100 - 1/1000; IHC-Fr: 1/100 - 1/1000.
Target
Alternative Names
SNCA; synuclein, alpha (non A4 component of amyloid precursor); PARK1, PARK4, Parkinson disease (autosomal dominant, Lewy body) 4; alpha-synuclein; alpha synuclein; NACP; PD1; synuclein alpha-140; non A-beta component of AD amyloid; PARK1; PARK4; MGC1109
Product Background
Antigen Description
May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.
Pathway
Alpha-synuclein signaling, organism-specific biosystem; Alzheimers disease, organism-specific biosystem; Alzheimers disease, conserved biosystem; Amyloids, organism-specific biosystem; Disease, organism-specific biosystem; EGFR1 Signaling Pathway, organism-specific biosystem; Parkinsons disease, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-8021 in a publication?
Let us know and earn a reward for your research.